Abstract
The inflammatory corpuscle recombinant absents in melanoma 2 (AIM2) and cholesterol efflux protein ATP binding cassette transporter A1(ABCA1) have been reported to play opposing roles in atherosclerosis (AS) plaques. However, the relationship between AIM2 and ABCA1 remains unclear. In this study, we explored the potential connection between AIM2 and ABCA1 in the modulation of AS by bioinformatic analysis combined with in vitro experiments. The GEO database was used to obtain AS transcriptional profiling data; screen differentially expressed genes (DEGs) and construct a weighted gene co-expression network analysis (WGCNA) to obtain AS-related modules. Phorbol myristate acetate (PMA) was used to induce macrophage modelling in THP-1 cells, and ox-LDL was used to induce macrophage foam cell formation. The experiment was divided into Negative Control (NC) group, Model Control (MC) group, AIM2 overexpression + ox-LDL (OE AIM2 + ox-LDL) group, and AIM2 short hairpin RNA + ox-LDL (sh AIM2 + ox-LDL) group. The intracellular cholesterol efflux rate was detected by scintillation counting; high-performance liquid chromatography (HPLC) was used to detect intracellular cholesterol levels; apoptosis levels were detected by TUNEL kit; levels of inflammatory markers (IL-1β, IL-18, ROS, and GSH) were detected by ELISA kits; and levels of AIM2 and ABCA1 proteins were detected by Western blot. Bioinformatic analysis revealed that the turquoise module correlated most strongly with AS, and AIM2 and ABCA1 were co-expressed in the turquoise module with a trend towards negative correlation. In vitro experiments demonstrated that AIM2 inhibited macrophage cholesterol efflux, resulting in increased intracellular cholesterol levels and foam cell formation. Moreover, AIM2 had a synergistic effect with ox-LDL, exacerbating macrophage oxidative stress and inflammatory response. Silencing AIM2 ameliorated the above conditions. Furthermore, the protein expression levels of AIM2 and ABCA1 were consistent with the bioinformatic analysis, showing a negative correlation. AIM2 inhibits ABCA1 expression, causing abnormal cholesterol metabolism in macrophages and ultimately leading to foam cell formation. Inhibiting AIM2 may reverse this process. Overall, our study suggests that AIM2 is a reliable anti-inflammatory therapeutic target for AS. Inhibiting AIM2 expression may reduce foam cell formation and, consequently, inhibit the progression of AS plaques.
Similar content being viewed by others
Introduction
According to survey data published in “The Lancet” in 2020, atherosclerosis (AS) affects the health of over 523 million people worldwide1. Ischemic heart disease caused by AS resulted in approximately 12 million deaths globally in 20192. Consequently, addressing the health crisis posed by AS is a challenge that cardiovascular physicians worldwide must confront.
A thorough understanding of the pathological mechanisms underlying the development of a disease forms the foundation for effective treatment. Although the pathogenic mechanisms of AS are complex, increased permeability follows endothelial cell injury leads to infiltration and aggregation of inflammatory cells (macrophages, lymphocytes) in the vascular intima occur, which are transformed into foam cells after phagocytosis of lipids. The accumulation of foam cells leads to the formation of lipid stripes and eventually lipid plaques, representing a crucial process in the occurrence of AS3. In this process, the foaming of inflammatory cells, particularly macrophages, after lipid was engulfed, is a pivotal step. Evidence suggests that macrophage-derived foam cells are the main source of foam cells in AS lesions4. Therefore, inhibiting the foaming of macrophages has become a current research focus in AS treatment.
Reverse cholesterol transport (RCT) refers to the process where high-density lipoprotein (HDL), acting as a receptor, transports cholesterol from extracellular cells, including macrophages, to the liver for breakdown and metabolism. Subsequently, the cholesterol is excreted from the body through the intestines. The normal RCT function of macrophages is crucial in preventing their foaming effectively5.
Recent reports have highlighted that the core protein of RCT: ATP-binding cassette transporter A1 (ABCA1), is continuously suppressed in the pathological process of AS. Additionally, the expression level of ABCA1 is negatively correlated with plaque progression6,7. Conversely, two other studies suggest that the AIM2 is highly expressed in AS plaques and positively correlates with plaque progression8,9. Therefore, the potential connection between ABCA1 and AIM2 has sparked our significant interest. To address this, we conducted bioinformatic analysis and in vitro experiments, aiming to unravel this question. This connection could be a key factor in macrophage foaming and might offer a new perspective for AS treatment.
Materials and methods
Bioinformatics
Data source and processing
Expression profiles and sample information from three datasets, GSE43292, GSE100927, and GSE24495, were downloaded from the Gene Expression Omnibus (GEO, https://www.ncbi.nlm.nih.gov/geo/) database. These datasets were annotated using the GPL6244 [HuGene-1_0-st] Affymetrix Human Gene 1.0 ST Array, GPL17077 Agilent-039494 SurePrint G3 Human GE v2 8 × 60 K Microarray 039381, and GPL10687 Rosetta/Merck Human RSTA Affymetrix 1.0 microarray platforms, respectively.
The GSE43292 collected 64 arterial intima samples, including 32 macroscopically intact tissue and 32 atheroma plaques, from 32 atherosclerosis patients. The GSE100927 included 104 peripheral artery samples, with atherosclerosis and control samples derived from peripheral arteries in the neck, femur, and below the knee region. This dataset comprised 44 control samples and 61 atherosclerosis samples. The GSE24495 included 113 carotid artery plaque samples from atherosclerosis patients. Since GSE100927 contained peripheral artery samples from the femur and below the knee region, only the carotid artery data was used in subsequent experiments (Table 1).
The bioconductor package in the R version 4.2.2 software was employed for background correction, normalization, and expression value calculation. The limma package in the R version 4.2.2 software was utilized to calculate differentially expressed genes (DEGs) between two groups, with a set threshold of adjusted P-value < 0.05 and expression fold change ≥ 2 (| log2FC |≥ 1.00) for DEG selection.
Weighted gene co-expression network analysis (WGCNA)
The expression matrix data of AS-DEGs was used to construct a POP-WGCNA network by the WGCNA package in the R version 4.2.2 software. The optimal soft-thresholding power (β) for creating a scale-free network was determined through the unscaled network approach. Subsequently, the adjacency matrix was generated by raising β to the power, and a topological overlap matrix was created using β exponentiation. A hierarchical clustering tree was then built with the topological overlap matrix as the basic element. Module division, merging, and gene dendrogram plotting were performed using the dynamic hybrid cut method.
After module division, characteristic vectors (module eigengenes, ME) for each module were computed. These MEs were correlated with clinical traits of AS patients and normal individuals. The Pearson correlation coefficient was used to assess the correlation between MEs and the clinical traits of the samples, defining the module with the highest correlation with AS as the hub module.
Correlation test
The Pearson correlation test completed the correlation analysis of the hub genes. The heat map drawing of the correlation between hub genes was completed by using the corrplot package in the R version 4.2.2 software. At the same time, Spearman correlation analysis and multiple linear regression analysis were performed on the expression of differentially expressed genes in GSE43292、GSE100927 and GSE24495.
In Vitro experiments
Cell culture
THP-1 cells were supplied by Procell Life Science&Technology Co., Ltd. (Wuhan, China) and cultured in RPMI-1640 medium (containing 10% FBS, 1% P/S) (Procell, Wuhan, China) at 37 ℃ and 5% CO2. THP-1 cells were stimulated with 100 ng/mL of phorbol myristate acetate (PMA) (Absin, Shanghai, China) for 72 h to induce their differentiation into macrophages, and the cell morphology was observed under electron microscope (Hitachi, Japan).
Cell transfection and grouping
To manipulate AIM2 expression in THP-1 macrophages, we transfected the cells with shRNA plasmids vectors and overexpression plasmids vectors targeting the expression of AIM2. And blank plasmids vectors were used to transduce THP-1 macrophages as a control group. All vectors were constructed by Chongqing Yitel Bioengineering Co., Ltd. (Chongqing, China). The THP-1 macrophages at 1× 106 cells/mL were inoculated in 6-well plates, and the plasmid vectors were transfected into the cells for 24 h according to the manufacturer’s protocol. To test the transfection efficiency, the supernatant was replaced with fresh RPMI-1640 medium, and the cells were incubated for another 1 h. The transfection efficiency was evaluated by performing real-time quantitative polymerase chain reaction (RT-qPCR) to detect AIM2 expression.
Cells were treated with oxidized low-density lipoprotein (ox-LDL, Solarbio, Beijing, China)10. According to the different treatments, THP-1 macrophages were divided into negative control (NC) group, model control (MC) group, overexpression AIM2 + ox-LDL (OE AIM2 + ox-LDL) group, and short hairpin RNA AIM2 + ox-LDL (sh AIM2 + ox-LDL) group. Except for the NC group, the other three groups were stimulated 4 h by adding 150 μg/mL ox-LDL to the cells after discarding the culture medium. Subsequently, replaced with fresh RPMI 1640 medium culture for 24 h. Then the cells were treated with 5 mM ATP(Beyotime Biotechnology,Shanghai, China) for 30 min and rinsed with PBS. The NC group was always cultured in fresh RPMI-1640 medium.
RNA isolation and RT-qPCR
As described previously, total RNA was extracted and quantified by Trelief® RNAprep FastPure (TsingkeBiotechnologyCo., Ltd. Beijing, China). Then, Goldenstar™ RT6 cDNA Synthesis Kit Ver.2 (Tsingke, Beijing, China) was used to synthesise RNA into cDNA; The TSE202 2 × T5 Fast qPCR Mix (SYBR Green I) (Tsingke, Beijing, China) was used to amplify the AIM2 gene, and it was quantified by real-time fluorescence quantitative PCR instrument (Bio-Rad, US). GAPDH was used as an internal reference gene, and the relative expression level of AIM2 gene was calculated according to the 2−ΔΔCt formula. AIM2 forward primer sequence: 5′-TCCACCCTCATGGGACCTGTAT-3′, AIM2 reverse primer sequence: 5′-TGGCAT- TTCGGGGCAACAT-3′. GAPDH forward primer sequence: 5'-AGGTCGGTGTGAACGGATTTG-3', reverse primer sequence: 5'-TGTAGACCATGTAGTTGAGGTCA-3'.
Detection of cholesterol efflux rate
The THP-1 macrophages of 1 × 106 cells/mL were inoculated into 6-well plates. Except for the NC group, the other three groups were incubated for 24 h with RPMI 1640 containing 0.2 μCi/mL 3H cholesterol after stimulating the cells with 150 μg/mL ox-LDL for 4 h. Subsequently, the cells were washed twice with PBS and balanced for 24 h by adding fresh RPMI-1640 medium. The supernatant was discarded and given 5 mM ATP to treat the cells for 30 min. Following the instructions of the total cholesterol assay kit (Nanjing Jiancheng bioengineering Institute, China) the radioactivity of 3H cholesterol in the cell supernatant and cell lysate was detected by liquid scintillation counting, respectively. The cellular cholesterol efflux rate was calculated according to the formula.
Detection of intracellular cholesterol levels
The levels of free cholesterol (FC), total cholesterol (TC) and cholesteryl esters (CE) in the cells were detected using High-performance liquid chromatography (HPLC) analysis. Briefly, the cells were washed twice with PBS, then 100 μL of TritonX-100 was added to fully lysed the cells, which were then mixed with 10 μL of enzyme reaction buffer and divided into two portions, followed by the addition of cholesterol oxidase and cholesterol esterase, respectively; Finally, 100 μL of methanol-ethanol (1:1) was added to terminate the reaction and the supernatant was collected to measure FC and TC. The CE is equal to the TC minus the FC.
Detection of apoptosis level
The cells were cultured in round coverslip, and the cells were grouped and treated as before. Before adding each reagent, the cells were rinsed with PBS for 3 times. The cells were fixed by adding 100μL of 4% paraformaldehyde fixative (Servicebio, Wuhan, China); followed by 100μL of 0.3% (v/v) Triton X-100 incubated for 5 min to permeabilize the cell membrane; then 50μL of TdT buffer (recombinant TdT enzyme: TMR-5-dUTP labelling mixture: equilibrium buffer = 1 μL: 5 μL: 50 μL (1:5:50)) was added to incubate for 10 min; subsequently, the cells’ nuclei were stained with DAPI for 5 min; and finally, the cells were blocked by using anti-fluorescence quencher. Confocal microscopy (HITACHI, Japan) was used to observe the apoptosis of cells in each group.
Western blot analysis
After rinsing the cells twice with PBS, RIPA lysis solution (containing PMSF and the protease inhibitor cocktail, Beyotime Biotechnology) was added and the cells were placed on ice for 10 min to fully lyse, and then the cell suspensions were centrifuged at 13,000 rpm for 20 min at 4 °C and collected supernatants. Protein quantification was performed with the BCA Protein Assay Kit (Beyotime Biotechnology). The proteins were mixed with SDS-PAGE protein uploading buffer (5 ×) (Epizyme, Shanghai, China) at a ratio of 4:1 and placed in a 100℃ dry bath incubator for 5 min to denature the proteins. Proteins were separated on 10% SDS-PAGE gel containing 60 μg of protein per lane. The separated proteins were then transferred to PVDF membranes (Amersham, German) which were closed in 5% skimmed milk for 1 h at room temperature. Then the PVDF membranes were incubated with anti-ABCA1 (abclonal A22125, 1:1000), AIM2 Rabbit pAB (abclonal A3356, 1:1000) and GAPDH (abclonal A 19056, 1:1000) at 4 °C overnight. The PVDF membranes were washed 3 times with TBST, followed by incubation with HRP-conjugated secondary antibody (Servicebio G1213,1:20000) for 1 h at room temperature. The PVDF membranes were rinsed 3 times with TBST, and then the immunoreactive bands were visualized on a nucleic acid protein gel imager (Bio-Rad, USA) by using enhanced BeyoECL chemiluminescent reagent (Beyotime Biotechnology).
Statistics
Statistical analyses were performed using GraphPad Prism version 9.5.1 software. All data are presented as mean ± standard deviation. Independent sample t-tests were employed for data comparison between two groups, and Pearson correlation analysis was utilized for correlation assessment. Fluorescent images were analyzed using Image J version 1.53 k software. A significance level of p < 0.05 indicated statistical significance, while p < 0. 01 denoted significant differences.
Results
Bioinformatics analysis results
Co-expression of AIM2 and ABCA1 in AS
To validate the co-expression relationship between AIM2 and ABCA1, we constructed a WGCNA for the merged dataset (AS et) from GSE43292 and GSE100927. The results are shown in Fig. 1, where the genes of AS et were assigned to a total of 20 co-expression modules, with the midnightblue module (0.62) and the turquoise module (0.61) being the most strongly associated with the AS phenotype (Fig. 1a).Furthermore, the midnight blue module had a correlation coefficient of 0.76, p-value of 1.7e-22 (Fig. 1b), and the turquoise module had a correlation coefficient of 0.68, p-value less than 1e-200 (Fig. 1c). These results indicate a significant correlation of both modules with the AS phenotype.
Clustering of modules and diseases was performed to screen the core set of genes. turquoise module and AS were clustered under the same subclass (Fig. 1d), suggesting that the genes in the turquoise module are most strongly associated with AS. Subsequently, we found that both AIM2 and ABCA1 belonged to the turquoise module. Therefore, it can be inferred that AIM2 and ABCA1 exhibit a co-expression pattern and are significantly correlated with AS.
Correlation in the expression levels of AIM2 and ABCA1
To further validate the correlation between AIM2 and ABCA1, we conducted Pearson and Spearman correlation analyses on AIM2 and ABCA family genes in AS et and clustered the genes based on their correlation. The results showed a correlation in the expression of AIM2 and ABCA1 in both the control and AS groups (Fig. 2a and b). To eliminate the potential impact of the control group on the experimental results, we performed the same analysis on GSE24495. The results demonstrated a correlation between AIM2 and ABCA1 in the AS samples alone (Fig. 2c and d).
Negative correlation in the expression levels of AIM2 and ABCA1
To delve into the specific relationship between AIM2 and ABCA1 expression levels in AS, we separately clustered the expression levels of AIM2 and the ABCA family in the AS et and GSE24495 datasets. The results indicate that in both healthy controls (HC) and AS samples, AIM2 and ABCA1 cluster together, suggesting that AIM2 and ABCA1 exhibit correlated differential expression levels in AS samples (Fig. 3a). However, in pure AS samples, AIM2 and ABCA1 did not cluster together. Moreover, the two primary gene clusters showed a trend of negative correlation in expression (Fig. 3b).
In Vitro experimental results
Induction of macrophages and foam cells
Following PMA induction for 24 h, THP-1 monocytes showed adherence, distortion, and extended pseudopods (as indicated by the arrow in Fig. 4a), indicating that THP-1 monocytes were successfully transformed into THP-1 macrophages. After the ox-LDL stimulated THP-1 macrophages for 4 h, the CE value was higher than 50% in the MC group compared with the NC group, indicating that THP-1 macrophages had been transformed into foam cells (Fig. 4b).
Effect of AIM2 gene overexpression/silencing on ox-LDL-induced lipid accumulation in THP-1 macrophages
We determined whether the AIM2 gene is involved in the process of foam cell formation. The results of lentiviral transfection of THP-1 macrophages showed that AIM2 was effectively silenced in the sh AIM2 group compared to the NC group, whereas the AIM2 mRNA level was significantly increased in the OE AIM2 group (Fig. 5a), indicating that lentiviral transfection was successful. After ox-LDL treated THP-1 macrophages, the cholesterol efflux rate was significantly reduced in the MC group compared to the NC group; AIM2 overexpression exacerbated the inhibition of cholesterol efflux rate in THP-1 macrophages by ox-LDL, whereas this inhibition was significantly alleviated when AIM2 was silenced (Fig. 5b and c). Meanwhile, HPLC analyses showed that FC and TC levels were elevated in THP-1 macrophages after ox-LDL intervention and were influenced by AIM2 levels (Fig. 5d and e). Excessive lipid accumulation in the cells resulted that the CE values were more than 50% in both MC and OE AIM2 + ox-LDL groups, and higher in the OE AIM2 + ox-LDL group (Fig. 5f). All these results suggested that AIM2 aggravated ox-LDL-induced lipid accumulation in THP-1 macrophages, leading to THP-1 macrophage foaminess.
The lipid levels of THP-1 macrophages. (a) mRNA expression levels of AIM2 after lentiviral transfection. (b-c) The Influence of AIM2 on the cholesterol efflux rate in THP-1 macrophages. (d-f) The Influence of AIM2 on TC, FC and CE levels in THP-1 macrophages. n = 3, Comparison with NC group, **p < 0.01; Comparison with MC group, ##p < 0.01.
Effect of AIM2 gene overexpression/silencing on ox-LDL-induced apoptosis in THP-1 macrophages
Macrophage apoptosis is a contributing factor to the accumulation of atherosclerotic damage and AS plaque instability. The apoptosis rate of ox-LDL treated THP-1 macrophages was significantly higher compared with that of the NC group, and there was a tendency for the apoptosis rate to increase in the OE AIM2 + ox-LDL group compared with that of the MC group, and apoptosis in the sh AIM2 + ox-LDL group decreased to some extent, although there was no statistical difference (Fig. 6). These results suggest that inhibition of AIM2 expression ameliorates macrophage apoptosis-induced AS.
Results of TUNEL detection for cellular apoptosis rate. (a) Fluorescent immunostaining image of TUNEL apoptosis, wherein nuclei of positively apoptotic cells emit red fluorescence, and DAPI staining reveals blue fluorescence in the nuclei(Scale, 50 μm). (b) Statistical findings of TUNEL in various cell groups post-intervention. n = 3, Comparison with NC group, *p < 0.05.
Effect of AIM2 overexpression/silencing on THP-1 macrophage oxidative stress and inflammatory factor levels induced by ox-LDL
AS is a chronic inflammatory disease, and in the inflammatory state macrophages phagocytose ox-LDL and differentiate into foam cells, generating large amounts of reactive oxygen species and inflammatory factors. AIM2 is a known inflammasome, and thus we evaluated the level of oxidative stress and inflammatory factors induced by the AIM2 gene on ox-LDL-induced THP-1 macrophages. Unsurprisingly, MC group cells showed elevated levels of inflammatory factors IL-1β and IL-18 as well as free radicals ROS and suppressed expression of antioxidant enzyme GSH after ox-LDL stimulation. AIM2 overexpression exacerbates the stimulatory effects of ox-LDL on oxidative stress and inflammatory responses. silencing of AIM2 effectively reversed the elevated levels of IL-1β, IL-18, and ROS, and the reduced levels of GSH (Fig. 7).
Results of cellular oxidative stress and inflammatory response in each group. (a-b) The Influence of AIM2 on inflammatory factors IL-1β, IL-18 levels in THP-1 macrophages. (c) The Influence of AIM2 on ROS levels in THP-1 macrophages. (d) The Influence of AIM2 on GSH levels in THP-1 macrophages. n = 6, Comparison with NC group,**p < 0.01;Comparison with MC group, ##p < 0.01.
Effect of AIM2 overexpression/silencing on ABCA1 and AIM2 protein expression in ox-LDL-induced THP-1 macrophages
We have demonstrated that both AIM2 and ABCA1 are core genes of AS with opposite trends. In addition, high expression of AIM2 inhibits cholesterol efflux rate from THP-1 macrophages. It has been shown that ABCA1, a key molecule in RCT, transports excess cholesterol out of the cell to maintain intracellular cholesterol homeostasis. Therefore, we believe that whether ABCA1 is regulated by AIM2 deserves to be further explored. As shown in Fig. 8a, compared with the NC group, AIM2 protein expression was significantly elevated and ABCA1 protein expression was suppressed in the MC group. Overexpression of AIM2 aggravated the inhibition of ABCA1compared with the MC group; on the contrary, silencing of AIM2 resulted in elevated ABCA1 protein expression. Subsequently, we conducted a correlation analysis between ABCA1 and AIM2, and the results showed that they were significantly negatively correlated (Fig. 8b), which verified the reliability of the results of this postgraduate letter analysis. The above results suggest that AIM2 is an upstream regulator of ABCA1 and that ABCA1 is negatively regulated by AIM2.
Discussion
Despite the substantial reduction in the associated risk events brought about by antiplatelet and lipid-lowering therapies in AS patients, there still exists other significant residual risks, such as inflammation. Inflammation is considered to play a driving role in the occurrence and development of AS. Similar to the positive effects of antiplatelet and lipid-lowering therapies, inhibiting the inflammatory response has a positive impact on the prognosis of AS patients11,12,13. Therefore, the medical community has been diligently exploring the clinical application of anti-inflammatory treatments for AS patients. However, our understanding of the mechanisms by which inflammation promotes the progression of AS is currently limited, potentially restricting the development of anti-inflammatory interventions. This study addresses this scientific question.
The AIM2 is a pattern recognition receptor with the function of specifically recognizing antigen signals. It identifies and binds cytoplasmic double-stranded DNA (dsDNA) from bacteria, viruses, vaccines, or self-cells14. When the HIN-200 domain at the C-terminus of AIM2 recognizes dsDNA, AIM2 recruits the adaptor protein ASC. ASC, as a crucial adaptor molecule, not only contains a PYD domain but also has a CARD domain that directly interacts with Caspase-1. The adaptor protein ASC recruits the effector protein Caspase-1 to the inflammasome complex. The formation of the AIM2 inflammasome brings Caspase-1 molecules close to each other, leading to the autocatalytic activation of Caspase-115. Subsequently, activated Caspase-1 cleaves pro-inflammatory cytokines IL-1β and IL-18 into their mature active forms, promoting the inflammatory response14,16.
ABCA1 is a major member of the ABC transporter family, with its human gene located on chromosome 9q31.1, spanning a total length of 149 kb. As a complete membrane transport protein, it consists of two spatially symmetrical transmembrane domains and two nucleotide-binding domains linked together. The latter serves as a specific target for adenosine triphosphate (ATP) binding, providing the energy needed for substance transmembrane transport17. ABCA1 exhibits higher levels in inflammatory cells such as macrophages, lymphocytes, and monocytes. The entire process mediated by ABCA1 in the reverse cholesterol transport (RCT) is as follows18: firstly, in the initial stage, ATP-driven ABCA1, through specific interaction with apolipoprotein AI, transfers excess cholesterol from macrophages in the arterial wall to the extracellular space, mediating HDL synthesis. Subsequently, cholesterol-enriched HDL is reshaped by phospholipid-cholesterol acyltransferase, forming mature HDL-C. Finally, free HDL-C in the plasma circulates to the liver, where it is recognized and taken up by the type I scavenger receptor, class B, member 1 (SR-BI), expressed on the liver surface. It enters the bile as neutral sterols through liver transport proteins ABCG5/ABCG8 or ABCA1 and is excreted in the feces. Studies have shown that ABCA1-mediated active cholesterol transport accounts for about half of macrophage RCT cholesterol transport16. Therefore, the expression level of ABCA1 directly affects the synthesis of blood HDL, inhibits RCT function, promotes lipid deposition in macrophages, and accelerates the formation of atherosclerotic plaques.
Based on our research results and previous literature reports7,19, we suspect that ABCA1 is a downstream target of AIM2. Overexpression of AIM2 may promote the expression of downstream inflammatory factors, thereby inhibiting the level of ABCA1, leading to dysfunction of macrophage RCT, causing lipid accumulation in macrophages, and ultimately resulting in macrophage foam cell formation.
As for the increase in AIM2 expression under ox-LDL stimulation, we suspect that it may be related to macrophage oxidative stress. Ox-LDL is a derivative particle of circulating LDL, produced after the oxidation of LDL, and is one of the strong oxidants20,21,22. Moreover, ox-LDL has a strong affinity with the scavenger receptors displayed on the macrophage membrane, making it easier to enter the macrophages and influence the intracellular environment. Among the target organelles of ox-LDL, mitochondria isone of the key factors for AIM2 activation.
Mitochondria is the main sites for producing ATP and is called the “powerhouses” of eukaryotic cells, providing energy for eukaryotic cell activities23. The normal life activities of organisms mainly depend on the normal function of mitochondria. Mitochondria participate in ATP synthesis through the tricarboxylic acid cycle, and the Electron Transport Chain (ETC) is the main mechanism for generating energy in mitochondria. ETC is mainly composed of five complexes. Electrons flow between complexes along the electrochemical gradient, with the help of Complex III (ubiquinone-cytochrome c oxidoreductase) and Complex IV (cytochrome c oxidase), and two mobile electron carriers: coenzyme Q10 and cytochrome c24,25,26,27. In the transfer process, electrons are transferred from the mitochondrial matrix to the inner mitochondrial membrane, generating an electrochemical proton gradient on the inner mitochondrial membrane28. Complex V (ATP synthase) depends on this process to oxidize adenosine diphosphate and phosphorylate it into ATP.
Although this process is relatively efficient, about 0.4% to 4% of oxygen cannot be completely reduced and produces the byproduct reactive oxygen species (ROS). Some level of ROS is necessary for maintaining healthy physiological processes and normal cellular functions, and it can be controlled by the cell's normal antioxidant stress mechanism to form a dynamic balance. However, when the exogenous oxidant ox-LDL intervenes, this balance is disrupted. It leads to dysfunction of the ETC, and the impaired ETC promotes the overproduction of ROS, creating a vicious cycle of oxidative stress and respiratory chain defects29,30.
Mitochondria are organelles with a double-layered phospholipid membrane structure, where the outer membrane has greater permeability than the inner membrane. This difference in permeability allows the maintenance of the electrochemical proton gradient on both sides of the mitochondrial inner membrane, a necessary condition for maintaining the mitochondrial membrane potential and playing a physiological role, as well as acting as a barrier to prevent the overflow of mitochondrial contents. However, the phospholipid membrane structure of mitochondria is highly susceptible to corrosion by ROS31, leading to reduced fluidity and increased permeability. This causes the release of mitochondrial contents into the cytoplasm, including dsDNA. Therefore, combining our ELISA results, we believe that ox-LDL induces oxidative stress in macrophages, increases the permeability of the outer mitochondrial membrane, activates AIM2 through the release of mitochondrial dsDNA, and ultimately leads to decreased ABCA1 expression.
However, this study still has its limitations, we just preliminarily explored the upstream–downstream relationship between AIM2 and ABCA1, but the specific mechanism of action between the two is still unclear and still needs further exploration. In addition, whether AIM2 is able to regulate other genes of the ATP-binding cassette transporter superfamily, such as ABCG1, which can be directly involved in HDL formation. We did not validate the potential link between ABCG1 and AIM2. In subsequent more in-depth studies, we will remedy this deficiency to contribute to a more comprehensive understanding of the supporting mechanisms of RCT and AS.
Conclusion
AIM2 is a reliable anti-inflammatory therapeutic target against AS. It inhibits ABCA1 expression, leading to abnormal cholesterol metabolism in macrophages and ultimately to foam cell formation. Therefore, inhibition of AIM2 may reverse this process and thus inhibit the progression of AS plaques.
Data availability
Data is provided within the manuscript and Supplementary Files.
References
Vos, T. et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 396(10258), 1204–1222 (2020).
Li, Y., Cao, G. Y., Jing, W. Z., Liu, J. & Liu, M. Global trends and regional differences in incidence and mortality of cardiovascular disease, 1990–2019: Findings from 2019 global burden of disease study. Eur. J. Prev. Cardiol. 30(3), 276–286 (2023).
Ference, B. A., Kastelein, J. J. P. & Catapano, A. L. Lipids and Lipoproteins in 2020. JAMA 324(6), 595–596 (2020).
Chistiakov, D. A., Melnichenko, A. A., Myasoedova, V. A., Grechko, A. V. & Orekhov, A. N. Mechanisms of foam cell formation in atherosclerosis. J. Mol. Med. (Berl) 95, 1153–1165 (2017).
Bäck, M., Yurdagul, A. Jr., Tabas, I., Öörni, K. & Kovanen, P. T. Inflammation and its resolution in atherosclerosis: Mediators and therapeutic opportunities. Nat. Rev. Cardiol. 16(7), 389–406 (2019).
Albrecht, C. et al. ABCA1 expression in carotid atherosclerotic plaques. Stroke 35, 2801–2806 (2004).
Gu, H. F. et al. Chronic unpredictable mild stress promotes atherosclerosis via HMGB1/TLR4-mediated downregulation of PPARγ/LXRα/ABCA1 in ApoE-/- mice. Front. Physiol. 10, 165 (2019).
Fidler, T. P. et al. The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis. Nature 592(7853), 296–301 (2021).
Lüsebrink, E. et al. AIM2 Stimulation impairs reendothelialization and promotes the development of atherosclerosis in mice. Front. Cardiovasc. Med. 7, 582482 (2020).
Ding, Y. et al. Protective role of sirtuin3 against oxidative stress and NLRP3 inflammasome in cholesterol accumulation and foam cell formation of macrophages with ox-LDL-stimulation. Biochem. Pharmacol. 192, 114665 (2021).
Hafiane, A. & Daskalopoulou, S. S. Targeting the residual cardiovascular risk by specific anti-inflammatory interventions as a therapeutic strategy in atherosclerosis. Pharmacol. Res. 178, 106157 (2022).
Wolf, D. & Ley, K. Immunity and Inflammation in Atherosclerosis. Circ. Res. 124(2), 315–327 (2019).
Soehnlein, O. & Libby, P. Targeting inflammation in atherosclerosis—From experimental insights to the clinic. Nat. Rev. Drug Discov. 20(8), 589–610 (2021).
Du, L., Wang, X., Chen, S. & Guo, X. The AIM2 inflammasome: A novel biomarker and target in cardiovascular disease. Pharmacol. Res. 186, 106533 (2022).
Hornung, V. et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514–518 (2009).
Wang, M. D., Franklin, V. & Marcel, Y. L. In vivo reverse cholesterol transport from macrophages lacking ABCA1 expression is impaired. Arterioscler. Thromb. Vasc. Biol. 27(8), 1837–1842 (2007).
Dergunov, A. D., Savushkin, E. V., Dergunova, L. V. & Litvinov, D. Y. Significance of cholesterol-binding motifs in ABCA1, ABCG1, and SR-B1 structure. J. Membr. Biol. 252, 41–60 (2019).
Chen, L., Zhao, Z. W., Zeng, P. H., Zhou, Y. J. & Yin, W. J. Molecular mechanisms for ABCA1-mediated cholesterol efflux. Cell Cycle 21, 1121–1139 (2022).
Tumurkhuu, G. et al. Chlamydia pneumoniae hijacks a host autoregulatory IL-1β Loop to Drive foam cell formation and accelerate atherosclerosis. Cell Metab. 28(3), 432-448.e4 (2018).
Hao, T. et al. Phosphatidylethanolamine alleviates OX-LDL-induced macrophage inflammation by upregulating autophagy and inhibiting NLRP1 inflammasome activation. Free Radic. Biol. Med. 208, 402–417 (2023).
Hui, B., Hou, X., Liu, R., Liu, X. H. & Hu, Z. Gypenoside inhibits ox-LDL uptake and foam cell formation through enhancing Sirt1-FOXO1 mediated autophagy flux restoration. Life Sci. 264, 118721 (2021).
Fang, D. et al. Electrochemical sensor based on micromotor technology for detection of Ox-LDL in whole blood. Biosens. Bioelectron. 217, 114682 (2022).
Hampl, V., Čepička, I. & Eliáš, M. Was the mitochondrion necessary to start eukaryogenesis?. Trends Microbiol. 27(2), 96–104 (2019).
Chade, A. R. & Hall, J. E. Role of the renal microcirculation in progression of chronic kidney injury in obesity. Am. J. Nephrol. 44(5), 354–367 (2016).
Schiffl, H. & Lang, S. M. Obesity, acute kidney injury and outcome of critical illness. Int. Urol. Nephrol. 49(3), 461–466 (2017).
Romagnani, P. et al. Chronic kidney disease. Nat. Rev. Dis. Primers 3, 17088 (2017).
Hazman, Ö. & Bozkurt, M. F. Anti-inflammatory and antioxidative activities of safranal in the reduction of renal dysfunction and damage that occur in diabetic nephropathy. Inflammation 38(4), 1–9 (2015).
Zhao, J. H. Mesangial cells and renal fibrosis. Adv. Exp. Med. Biol. 1165, 165–194 (2019).
Liu, Y. et al. Mitochondrial dysfunction and therapeutic perspectives in cardiovascular diseases. Int. J. Mol. Sci. 23(24), 16053 (2022).
Zhao, R. Z., Jiang, S., Zhang, L. & Yu, Z. B. Mitochondrial electron transport chain, ROS generation and uncoupling (Review). Int. J. Mol. Med. 44(1), 3–15 (2019).
Fouret, G. et al. The mitochondrial-targeted antioxidant, MitoQ, increases liver mitochondrial cardiolipin content in obesogenic diet-fed rats. Biochim. Biophys. Acta. 1847, 1025–1035 (2015).
Funding
This research was supported by 2020 Hainan Medical College Scientific Research Cultivation Fund Project (HYPY202005), The Second National Famous Traditional Chinese Medicine Inheritance Studio (Yang Hua Studio) ([2022] No.245), Natural Science Foundation of Hainan Province (822QN476), TCM Geriatrics Construction Project, Key Discipline of National Administration of TCM (2023No3).
Author information
Authors and Affiliations
Contributions
S.Z. and S.S. wrote the main manuscript text, their contributions to this study are the same, so S.Z. and S.S. are the co-first authors. Z.W. prepared all figures and tables. M.Z. and C.W were responsible for data analysis. K.C. and D.L were responsible for the design and review of the study, they are the co-corresponding authors of this study. All authors reviewed the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhuo, S., Song, S., Wang, C. et al. Inflammatory corpuscle AIM2 facilitates macrophage foam cell formation by inhibiting cholesterol efflux protein ABCA1. Sci Rep 14, 10782 (2024). https://doi.org/10.1038/s41598-024-61495-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-024-61495-4
Keywords
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.